The search for clinically effective topical percutaneous local anaesthetic formulations has been undertaken over the past 30 years. It is generally agreed that the ideal formulation should provide rapid, deep and relatively long lasting anaesthesia of both the skin surface and the underlying tissues [1] [2] [3] [4] . Percutaneous local anaesthesia is of particular value in paediatric practice. The stress involved on admission of the sick child to hospital has been studied by Blom [5] . Stress can make relatively minor procedures such as venepuncture and insertion of catheters more difficult for both physician and child than is intrinsically necessary [6] . Clearly, there is a need for an anaesthetic preparation which would render such procedures painless. Since infiltration anaesthesia is in itself painful, a topical preparation which allows the anaesthetic to penetrate the skin barrier (stratum corneum) and anaesthetize the underlying pain receptors is required. Additionally, percutaneous local anaesthesia may permit surgical procedures such as split-skin grafting to be undertaken painlessly without the need for general or infiltration anaesthesia.
The stratum corneum is the main barrier to the absorption of drugs through the skin [7] . Thus various percutaneous anaesthetic formulations have been studied for their efficacy at promoting penetration of the barrier by the anaesthetic agent. Unfortunately, these formulations have several disadvantages and, therefore, do not meet the ideal profile for a percutaneous local anaesthetic preparation. For example, dimethylsulphoxide (DMSO) has been used successfully in formulations to enhance the penetration of local anaesthetics, but the adverse side-effects, which were attributed to DMSO, were unacceptable [8, 9] . Although Lubens and colleagues [10] successfuly used lignocaine in a cream base to provide painless venepuncture in children, the drug concentration required was unacceptably high (30%w/w). More recently, Hallen, Ohlsen and Uppfeldt [4] studied the anaesthetic effect of a gel containing a mixture (5%w/w) of lignocaine and prilocaine. However, their results indicated that a minimum application period of 1 h (with occlusion) was required to provide adequate anaesthesia.
Local anaesthetics do not readily penetrate the intact epidermal barrier. It is possible, therefore, that some previous attempts to optimize percutaneous local anaesthetic formulations have been compromised by the inappropriate choice of the actual local anaesthetic agent. In the present study the percutaneous absorption of a number of local anaesthetics is compared both in vitro and in vivo, with the aim of selecting a suitable drug for development into an optimum formulation.
SUBJECTS, MATERIALS AND METHODS

Chemicals
All materials used were of pharmacopoeal or equivalent quality. Local anaesthetics were in the form of the free base. If the base was not commercially available it was prepared from its water-soluble salt by precipitation with potassium hydroxide 4 mol litre"
1 . The free base was removed by filtration, recrystallized from an appropriate solvent, washed with water and dried under vacuum. Amylocaine base was an oily liquid and was removed by centrifugation, washed with water and dried over anhydrous magnesium sulphate.
Local anaesthetic formulations
Local anaesthetics (in the form of their free bases) were formulated as oil/water (o/w) creams using emulsifying wax (18%), liquid paraffin (4.5%) and water (77.5%). Formulations were prepared on an equimolar basis to contain in each case 0.035 mol of anaesthetic base per 100 g of cream. ). The absorption cell was maintained at 32 + 0.5 °C while the receiving fluid (Ringer's solution) was held at 37 + 0.5 °C ( fig. 1 ). The receiving fluid (130 ml) was delivered at a rate of 14 ml min" 1 . The presence of drug in the receiving (sink) phase was monitored spectrophotometrically (Perkin Elmer 554 Spectrophotometer). Concentrations of each drug appearing in the receiving fluid were calculated by reference to a previously prepared calibration curve. Each formulation was run in triplicate.
In vivo studies
These were undertaken on 15 healthy volunteers (9 male) who each gave written informed consent. The study was approved by the University Ethical Committee. The trial for each local anaesthetic formulation was double-blinded using the o/w cream (without anaesthetic) as the control. Application of local anaesthetic/control to the left or right arm was allocated in a random fashion. A minimum period of 7 days was maintained between successive trials on previously treated individuals.
Each formulation was applied (0.5 g) to the ventral surface of the forearm and covered with an Op-Site dressing for 30 min, after which the cream was removed, the site swabbed with 70 % alcohol and the area delineated with an indelible marker. 
Water bath
Initially, anaesthesia was assessed at 5-min intervals by pricking the skin six times in such a manner as to cover the treated area. If pain was not felt the sterile needle was slowly pushed into the skin until pain was perceived or to a final depth of 9 mm. The depth to which anaesthesia could be detected was graded on a scale 0-2:0 = no anaesthetic effect; 1 = some depth of anaesthesia was apparent; 2 = anaesthesia of all the layers tested.
Calculation of in vitro penetration
The steady-state flux (Q A ) of each anaesthetic across unit membrane area was obtained from the slope of the drug concentration (sink) v. time plot via regression analysis of the linear (steady-state) section. The lag times were obtained by extrapolation of the linear plot to the time axis [11] .
The permeability coefficient (P) was obtained from:
donor phase (mg ml *) and x is thickness.
Statistical analysis of in vivo trial
The percutaneous anaesthetic efficacy of each anaesthetic was assessed against a placebo by means of a chi-square test on a 2 x 2 contingency table. A continuity correction [12] was applied to the calculation of the chi-square statistic, since the numbers in the test were relatively small. A comparison of the efficacy of amethocaine and Hgnocaine was made by a chi-square test on a 3 x 2 contingency table produced by noting the numbers of volunteers reporting each perceived pain category for these drugs.
RESULTS
In vitro assessment (table I) of the various anaesthetic formulations indicated that penetration of the silastic membrane was dependent on the local anaesthetic used. Penetration efficiency, as judged by the apparent permeability coefficient, was in the order, Hgnocaine > amethocaine > fomocaine > benzocaine > amylocaine > cinchocaine > mepivacaine > bupivacaine. The last compound showed no penetration through the silastic membrane. The lag time for first appearance of drug in the receptor phase ranged from 18 min for amethocaine to 31 min for mepivacaine.
When the local anaesthetic formulations were tested in vivo (table II) the amethocaine formulation showed a 75 % success rate, whereas Hgnocaine was 50% effective in providing percutaneous local anaesthesia. Bupivacaine, cinchocaine and mepivacaine provided no anaesthesia in any of the 15 volunteers.
Statistical analysis of the in vivo study indicated that only amethocaine, amylocaine, benzocaine and Hgnocaine produced a significant anaesthetic effect when compared with placebo (table III) .
A statistical comparison of the amethocaine and Hgnocaine formulations indicated that the former produced superior percutaneous local anaesthesia, particularly with regard to the depth to which anaesthesia could be obtained (table IV) .
DISCUSSION
The purpose of the present study was to attempt to select, on a rational basis, local anaesthetic agent(s) with potential percutaneous local anaesthetic activity. For this reason an initial in vitro assessment of the anaesthetic agents was undertaken by examining their penetration of a standard lipophilic membrane. Silastic (dimethylpolysiloxane) is an isotropic polymer which has been well established for use as a lipophilic membrane with respect to drug absorption [11, 13, 14] . Therefore, it offers a good comparative model of drug penetration by passive diffusion through the skin barrier (stratum corneum) when the lipophilicity of the penetrant is thought to be of prime importance as in the case of local anaesthetics. The Sartorious absorption simulator used for these in vitro studies was modified in our laboratory to allow the absorption cell and receiving fluid to be maintained at different temperatures (32 and 37 °C, respectively), thus simulating the in vivo situation more closely. A further modification permitted a larger volume of receiving fluid to be used, thus effectively maintaining sink conditions during the course of the investigation. The advantage of using an in vitro model is to provide reproducible quantitative data under carefully controlled conditions.
The local anaesthetic agents studied were chosen on the basis of their reported potency, lipophilicity, availability and widespread use. Fomocaine was included because of its reported efficacy as a topical anaesthetic [15] . A standard water-miscible cream formulation was used in all cases for comparative purposes. Each local anaesthetic was formulated on an equimolar rather than an equipotent basis because, in the case of percutaneous absorption, the drug must initially be capable of reaching its target site before exerting an anaesthetic effect. For this reason, differences in drug potencies are virtually irrelevant. Furthermore, drug release from a formulation matrix (cream in the present study) and the establishment of a concentration gradient across a membrane are dependent upon drug concentration; hence, the latter had to be kept constant for each formulation.
It is interesting to observe that all formulations (except bupivacaine which did not penetrate the barrier) exhibited a characteristic lag phase (table I) followed by steady-state permeation of the barrier membrane. It would also appear that the steady-state flux values decrease for different anaesthetics (table I) , as the apparent lag time tends to increase. This phenomenon has been previously reported for other drug absorption profiles using various silastic membranes [11] . This lag period can be interpreted as the time required for diffusion of drug molecules into and through the barrier before appearing in the receiving fluid.
It is clear from table I that, of the local anaesthetics examined in vitro, the highest apparent steady state flux values obtained were for amethocaine, lignocaine and fomocaine, respectively. A better comparison made on the basis of calculated permeability coefficients (which takes into account the actual drug concentration present in each case) indicates that the efficacy of penetration was in the order lignocaine > amethocaine > fomocaine > benzocaine. Bupivacaine, a potent local anaesthetic, was the most lipophilic agent studied (as determined by the logarithm of the octanol/water partition coefficient, log P), but nevertheless failed to penetrate the silastic barrier. Lignocaine and amethocaine showed similar penetration properties, despite the greater log P value of the latter drug [16] . The low steady-state flux of mepivacaine, however, might have been expected on the basis of its small log P value [16] . A reasonable conclusion from these results is that affinity of the drug for the vehicle is a factor additional to lipophilicity in controlling penetration of the barrier membrane.
Although in vitro studies are of use in the design of percutaneous drug absorption systems, they cannot account for the differences in potencies of the various agents studied. Thus, a volunteer trial of the anaesthetic formulations was also carried out. Although a wide variety of stimuli have been used to induce pain, including physical, chemical and electrical methods [17, 18] , the simplest and perhaps the most appropriate of these methods involves pricking of the skin with needles [19, 20] . Therefore, the latter technique was chosen as being the most suitable for detecting percutaneous anaesthesia in this study. Initial pin-pricking was followed by insertion of the needle to the skin to mimic venepuncture and to differentiate between surface and full-depth anaesthesia. Also, it can be difficult to reproduce exactly the pin-pricking procedure from one individual to another; hence, the insertion of the needle through the skin was the final test of assessment of anaesthesia. Statistical analysis of the results (table III) indicated that only amethocaine, lignocaine, amylocaine and benzocaine produced a clinical response significantly different from that of placebo. At a higher level of significance (P = 0.01) only amethocaine and lignocaine proved better than placebo. Interestingly, these agents also performed best in the in vitro study. A detailed comparison between amethocaine and lignocaine (table IV) in terms of their ability to produce full-depth percutaneous local anaesthesia indicated that amethocaine was significantly superior to lignocaine. Although their in vitro penetration characteristics were similar, amethocaine has an anaesthetic potency approximately 2.5 times greater than lignocaine [15] . Furthermore, although both drugs had similar lag times in vitro, the onset of anaesthesia in vivo (measured from the initial time of application) was considerably more rapid, and the average duration of effect longer, with amethocaine than with lignocaine (table II) .
Of the other anaesthetics in the study mepivacaine, with an anaesthetic potency similar to lignocaine, had no apparent percutaneous anaesthetic activity (table II) , in contrast to a previous report [3] . It did not penetrate the silastic membrane as effectively as some other local anaesthetics. This could possibly be attributed to the fact that the formulation used (alcoholic base) was quite different from that used in this investigation. Furthermore, since these workers used pain stimuli based on electrical stimulation of C fibres and the use of u.v. irradiation, it is possible that the combination of these factors could well explain the different results obtained.
Fomocaine was orginally developed as a highly lipophilic agent designed for topical administration. Although it had a reasonably high flux value in the in vitro study, the drug either did not have sufficient potency to produce a complete response in vivo or, more likely, it was trapped in the lipophilic membranes of the epidermal layers. The fact that the other local anaesthetics were found to be clinically ineffective was also reflected in the smaller apparent steady-state flux values observed (table I) .
The results of the present study indicate that assessment of topical local anaesthetic formulations in vitro and in vivo identified amethocaine as the most promising percutaneous anaesthetic agent. Since local anaesthetics, as a drug group, do not readily penetrate skin, further work is required to produce an optimum amethocaine formulation which will most closely meet the requirements for an ideal percutaneous local anaesthetic formulation.
